Listen to the recent ALC lunch presso given by Nathan Buzza. Alcidion are a long way off from selling anything in the US. They have a "road map" they intend to follow to be authorised by the FDA to sell the software. Yes Australia looks like it is going well, but can that support the current market cap? There is strong support at 5c, but the placement was 3c so I think there is a risk the share price gets referenced by that eventually if there is no news flow out of the US, which there won't be. IMO. But that's just fundamentals, and as we have seen with many biotechs they can run strongly for no apparent reason.
The Brains Trust - 2016, page-4528
-
- There are more pages in this discussion • 10,024 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add XSO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2,972.9 |
Change
4.300(0.14%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 2,968.6 | 2,992.7 | 2,968.0 |
| XSO (ASX) Chart |